{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:12:52Z","timestamp":1761178372700,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.canrad.2007.09.148","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T11:24:39Z","timestamp":1198668279000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy"],"prefix":"10.1016","volume":"12","author":[{"given":"R.","family":"Mes\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Majem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Barretina Ginesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Galiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ma\u00f1\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Guedea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Monner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cardenal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2007.09.148_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib3","first-page":"285s","article-title":"Impact on quality of life of the addition of docetaxel to neoadjuvant cisplatin plus 5-fluorouracil treatment in patients with locally advanced unresectable squamous cell carcinoma of the head and neck: an EORTC study 24971","volume":"24","author":"Bernier","year":"2006","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canrad.2007.09.148_bib5","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canrad.2007.09.148_bib6","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1200\/JCO.2000.18.18.3320","article-title":"Reduction of distant metastases in head and neck cancer with concomitant chemotherapy","author":"Brocksein","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canrad.2007.09.148_bib8","first-page":"280s","article-title":"Randomized phase III trial comparing induction chemotherapy using cisplatin, 5-fluorouracil with or without docetaxel for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-2001","volume":"24","author":"Calais","year":"2006","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib9","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1200\/JCO.1999.17.11.3503","article-title":"Phase II trial of docetaxel, cisplatin, fluorouracil and leucovorin as induction for squamous cell carcinoma of the head and neck","volume":"17","author":"Colevas","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0360-3016(97)85494-6","article-title":"A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced aquamous cell carcinoma of the pharynx","volume":"35","author":"Cummings","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2007.09.148_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canrad.2007.09.148_bib13","doi-asserted-by":"crossref","unstructured":"Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx. Induction Cisplatin\/5FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol, 2006 ASCO Annual Meeting Proceedings art I. Vol 24, No 18S, 2006:5517.","DOI":"10.1200\/jco.2006.24.18_suppl.5517"},{"key":"10.1016\/j.canrad.2007.09.148_bib14","unstructured":"Fortin A, Albert M, Eric V, Josee A. Histologic grade as an independent predictor of distant metastases in head and neck cancers. Proc ASCO 2000;19:411a (A1647); 2000."},{"key":"10.1016\/j.canrad.2007.09.148_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2007.09.148_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(02)00141-X","article-title":"Twice-a-day radiotherapy for head and neck cancer: the Catalan Institute of Oncology experience","volume":"64","author":"Galiana","year":"2002","journal-title":"Radiother. Oncol."},{"year":"1987","series-title":"International Union Against Cancer (UICC). TNM classification of malignant tumors. 4th edition","key":"10.1016\/j.canrad.2007.09.148_bib17"},{"key":"10.1016\/j.canrad.2007.09.148_bib18","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin and 5-fluoruracil versus cisplatin, 5-fluoruracil and Paclitaxel as induction therapy in locally advanced head and neck cancer","author":"Hitt","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/annonc\/mdf268","article-title":"Induction chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil for squamous cell carcinoma of the head and neck: long term results of a phase II trial","volume":"13","author":"Hitt","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib22","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group","volume":"324","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canrad.2007.09.148_bib24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.2000.18.7.1458","article-title":"Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial","volume":"18","author":"Jeremic","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation for incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.canrad.2007.09.148_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hed.10385","article-title":"Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck","volume":"26","author":"Kotz","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2007.09.148_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canrad.2007.09.148_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00405-004-0749-5","article-title":"Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma","volume":"262","author":"Le\u00f3n","year":"2005","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.canrad.2007.09.148_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/01.mlg.0000231736.08477.47","article-title":"Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catal\u00e0 d\u2019Oncologia in stage III larynx carcinoma","volume":"116","author":"Majem","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2007.09.148_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","article-title":"Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck","volume":"88","author":"Merlano","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canrad.2007.09.148_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/annonc\/mdh101","article-title":"Dysphagia following chemoradiation for locally advanced head and neck cancer","volume":"15","author":"Nguyen","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/86.4.265","article-title":"Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo","volume":"86","author":"Paccagnella","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canrad.2007.09.148_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2007.09.148_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(91)90670-Y","article-title":"Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma","volume":"21","author":"Pinto","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2007.09.148_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2001.19.4.1096","article-title":"Multicenter phase I\u2013II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck","volume":"19","author":"Posner","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib37","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/j.canrad.2007.09.148_bib38","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1200\/JCO.2001.19.13.3234","article-title":"Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer","volume":"19","author":"Robert","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib39","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/00005537-200012000-00019","article-title":"Neoadjuvant therapy for organ preservation in head and neck cancer","volume":"110","author":"Urba","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2007.09.148_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/j.canrad.2007.09.148_bib41","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2000.18.8.1652","article-title":"Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer","volume":"18","author":"Vokes","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib42","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2007.09.148_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hed.20465","article-title":"Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis","volume":"29","author":"Winquist","year":"2007","journal-title":"Head Neck"},{"year":"1979","series-title":"Handbook for reporting results of cancer treatment. WHO offset publication no. 48","key":"10.1016\/j.canrad.2007.09.148_bib44"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321807002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321807002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:13:45Z","timestamp":1761135225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321807002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1278321807002727"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2007.09.148","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2007.09.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}